Liver disease is a global challenge, and advancing care starts with understanding how #hepatology is practiced worldwide.
Participate in the Global Hepatology Survey, in collaboration with EASL, ALEH, SOLDA, and APASL.
🗓 Open through March 31
🌍 Available in 4 languages
👉 https://bit.ly/4rOPJHI
Three days left to apply for AASLD’s 2026 Transplant Hepatology Fellowship Matching Program! Pursue eligibility for an #ABIM and/or #ABP certification early when you match with a transplant hepatology fellowship. Applications close at 8 p.m. EST on March 6. https://bit.ly/3oQOYQo
03.03.2026 18:10 — 👍 0 🔁 0 💬 0 📌 0
AASLD is proud to collaborate with leading global organizations on a new consensus document guiding the diagnosis, staging, and management of alpha-1 antitrypsin deficiency–associated liver disease in adults.
View the consensus document in Gastroenterology. https://bit.ly/4snHRNl
Now Open: 2026 Distinguished Award Nominations
Learn more about the awards and start your nomination: https://bit.ly/3MD0xJN
In celebration of #WomensHistoryMonth, AASLD is spotlighting research that advances understanding of women’s #liverhealth and strengthens equity across #hepatology.
https://bit.ly/3ZsOS0I
Today is #RareDiseaseDay. At AASLD, we are committed to advancing education, research, and advocacy that support individuals living with rare #liverdiseases.
View these perspectives from AASLD members who are driving progress in rare liver disease research, diagnosis, and care.
"As we recognize #RareDiseaseMonth this February and #RareDiseaseDay on February 28, I confirm my own, and the entire AASLD membership’s, commitment to the rare liver disease community."
View the letter: https://bit.ly/4aCqQZE
In recognition of #RareDiseaseMonth, check out this special Rare Liver Disease collection from #AASLD publications. These articles highlight clinical expertise and innovation to accelerate discovery where it's needed most.
👉 https://bit.ly/4rFiAOG
🔥HOT TOPIC in #LiverTransplantation
This clinical trial shows that a structured, supervised exercise program significantly improves brain blood flow & cognitive function in patients with #MASLD, revealing powerful benefits that extend well beyond the #liver.
📙Full study: https://bit.ly/3NVFMZX
This #BlackHistoryMonth, AASLD spotlights the role of public policy in advancing #liverhealth equity. Evidence-based policies are essential to expanding access to prevention, early diagnosis, and treatment of liver diseases.
➡️ Learn more: https://bit.ly/4ckbExT
📙Explore the latest Practice Guideline from #AASLD and American Society of Transplantation, published in #LiverTransplantation.
➡️ Read more: https://bit.ly/4anvTNt
AASLD’s 2026 Transplant Hepatology Fellowship Matching is still accepting applications! Tailor your experience and use AASLD as your agent in matching you with an invaluable fellowship. Start your application! https://bit.ly/3oQOYQo
20.02.2026 15:45 — 👍 0 🔁 0 💬 0 📌 0
🔥HOT TOPIC in #HepatologyCommunications
A new systematic review of 68 randomized trials suggests albumin infusion in cirrhosis may reduce mortality & complications, while highlighting the need for more rigorous evidence to fully understand its benefits & risks.
💻Full study: https://bit.ly/4qV49p9
This #BlackHistoryMonth, AASLD spotlights members whose work advances science, equity, and care.
#Gastroenterology Nurse Practitioner Pamela Barr, MSN, FNP-C is passionate about providing high-quality, patient-centered care across the lifespan, with a focus on serving underserved communities.
Co-Editors-in-Chief Elliot B. Tapper, MD, FAASLD, and Carmen Chak-Lui Wong, PhD, share highlights from the February issue of #HepatologyCommunications.
Watch below and view the latest issue here: https://bit.ly/4sf5gBm
https://www.youtube.com/watch?v=AOUNOg3JYew
This #ValentinesDay, we’re celebrating the heart of our community, the dedicated members of #AASLD.
❤️ Thank you for all you do to advance #hepatology, promote #liverhealth, and transform lives through quality patient care.
One Month Out! The AASLD Emerging Topic Conference (ETC) is designed to examine how interconnected evidence across #liverdisease informs clinical and translational decision-making. View the program and register: https://bit.ly/3KHXpeG
13.02.2026 13:00 — 👍 0 🔁 0 💬 0 📌 0
🔥 HOT TOPIC in #HEPATOLOGY
This landmark study shows that vibration-controlled transient elastography provides prognostic accuracy comparable to histology in #MASLD, supporting liver stiffness measurement as a noninvasive surrogate endpoint for clinical trials.
📗Read more: https://bit.ly/4c7gulx
This #BlackHistoryMonth, AASLD spotlights members whose work advances science, equity, and care.
Julius M. Wilder, MD, PhD, Chair of the #AASLD Public Policy Committee, shares how research, advocacy, and evidence-based policy can drive real progress toward health equity.
This #BlackHistoryMonth, AASLD spotlights members whose work advances science, equity, and care.
Rotonya Carr, MD, FACP, FAASLD shares an important message on the resilience of our #hepatology field and the legacy of Black leadership in medicine.
@who.int is considering expanding its NCD definition to include liver disease, reflecting growing recognition of liver health as central to integrated, lifelong care and prevention. AASLD welcomes this important step for global liver health!
Learn more: https://bit.ly/4ckbExT
Your perfect match starts with AASLD’s Transplant Hepatology Fellowship Matching Program! Let AASLD be your agent in matching with reputable institutions and mentors in #transplant hepatology — apply now. https://bit.ly/3oQOYQo
06.02.2026 14:00 — 👍 0 🔁 0 💬 0 📌 0
Don’t miss the #WorldHepatitisSummit 2026 held in Bangkok, Thailand on Apr. 28-30.
Register by Feb. 24 to secure early bird rates. https://bit.ly/4sEMDXN
View the first message of the year from 2026 #AASLD President Dr. Saul Karpen!
https://bit.ly/4a43mLz
Join us in ONE HOUR for this valuable webinar! Claim your spot to identify the indications, limitations, and the application of TIPS in patients with #cirrhosis and variceal bleeding. Claim my spot. https://bit.ly/49Yljv5
27.01.2026 16:00 — 👍 0 🔁 0 💬 0 📌 0
Introducing the new #AASLD Publications Showcase Page on LinkedIn!
Stay current on the leading science and practice-changing studies across #HEPATOLOGY, #LiverTransplantation, and #HepatologyCommunications.
🔗Explore the new page here: https://bit.ly/3LHzv3o.
Moderated by Virginia Hernandez-Gea, MD, PhD, be part of the discussion on the differences between rescue versus pre-emptive TIPS in patients with #cirrhosis and variceal bleeding. Register now for the January 27 webinar. https://bit.ly/49Yljv5
25.01.2026 17:28 — 👍 0 🔁 1 💬 0 📌 0
This must-read resource brings together the latest recommendations on immunosuppression, rejection, recurrent disease, and emerging advances to support optimal long-term outcomes and elevate the future of transplant care.
➡️ Read more in #LiverTransplantation: https://bit.ly/3NzlIwj.
⚠️ We need your help!
Contact your senators today and urge them to pass the FY26 Labor–HHS appropriations bill to ensure predictable funding for NIH, CDC, and other critical health agencies.
📩 Take action now using the #AASLD Policy Action Center: https://bit.ly/3YVavso. #FY26Budget
Thank you to AASLD Past President Dr. Grace L. Su and @endocrinesociety.bsky.social for raising awareness today on Capitol Hill!
#AASLD continues to advocate and educate to promote #liverhealth and quality patient care.
Learn more about AASLD’s public policy work here: https://bit.ly/4ckbExT.
